Histiocytoid breast carcinoma, neither lobular nor ductal? A case report and literature review. 2020

Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
Department of Pathology, Hebei General Hospital, Shijiazhuang, China.

Histiocytoid breast carcinoma (HBC) is a rare type of breast cancer with controversial histogenesis, which is characterized by abundant foamy cytoplasm, fuzzy cell boundary, linear or annular infiltration, eccentric large irregular nuclei or prominent nucleoli and low mitotic activity. HBC has been considered to be a variant of lobular carcinoma, a variant of apocrine ductal carcinoma, and an apocrine variant of lobular carcinoma and to resemble lipid-rich carcinoma. We presented a case of 75-year-old woman with a 5-cm mass in the left breast. The mass was yellow-beige on cut section. HBC was diagnosed including invasive carcinoma (IC) of apocrine differentiation (diameter about 5 mm) which was surrounded by extensive carcinoma in situ (CIS, diameter about 25 mm) of apocrine type, and a 4-mm invasive ductal carcinoma (IDC) in grade II. The distance between HBC and IDC was 4 mm. There was extensive (42 of 43 lymph nodes) metastasis and intravascular tumor emboli. The tumor extended into peripheral nerve. The pathology showed histiocytoid breast carcinoma with a smaller conventional invasive ductal carcinoma in adjacent area. She received a left modified radical mastectomy. However, on the follow-up imaging techniques, the mass showed no response. We discussed the pathology and immunohistochemical finding, and reviewed the literatures. We found that this case was a unique type of HBC.

UI MeSH Term Description Entries

Related Publications

Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
December 2021, Annals of medicine and surgery (2012),
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
August 2023, The American surgeon,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
June 2003, Annales de pathologie,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
October 1992, Revue medicale de la Suisse romande,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
April 1998, Gynecologic oncology,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
August 2011, Journal of clinical pathology,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
November 1993, Journal of forensic sciences,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
May 1989, Histopathology,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
April 2018, The American journal of case reports,
Xiao-Li Ma, and Qian Du, and Yang Liu, and Rong-Mei Zhao, and Shu-Yan Zhang, and Huan-Fen Zhao
December 2018, Journal of breast cancer,
Copied contents to your clipboard!